TabMenu

Poverty and InequalitySexual and Reproductive HealthFamily, Maternal & Child HealthComputational Population & Health SciencesMethodology

Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States

TitleModeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States
Publication TypeJournal Article
Year of Publication2016
AuthorsOzawa, S, Portnoy, A, Getaneh, H, Clark, S, Knoll, M, Bishai, D, Yang, HK, Patwardhan, PD
JournalHealth Aff (Millwood)
Volume35
Pagination2124-2132
Date PublishedNov 01
ISBN Number0278-2715
Accession Number27733424
KeywordsCost of Health Care, Health Economics, Health Spending, Public Health
Abstract

Vaccines save thousands of lives in the United States every year, but many adults remain unvaccinated. Low rates of vaccine uptake lead to costs to individuals and society in terms of deaths and disabilities, which are avoidable, and they create economic losses from doctor visits, hospitalizations, and lost income. To identify the magnitude of this problem, we calculated the current economic burden that is attributable to vaccine-preventable diseases among US adults. We estimated the total remaining economic burden at approximately $9 billion (plausibility range: $4.7-$15.2 billion) in a single year, 2015, from vaccine-preventable diseases related to ten vaccines recommended for adults ages nineteen and older. Unvaccinated individuals are responsible for almost 80 percent, or $7.1 billion, of the financial burden. These results not only indicate the potential economic benefit of increasing adult immunization uptake but also highlight the value of vaccines. Policies should focus on minimizing the negative externalities or spillover effects from the choice not to be vaccinated, while preserving patient autonomy.